Spironolactone, a medication commonly used to lower blood pressure and for treating heart-related problems, shows potential for the treatment of alcohol use disorder.
Age-related changes in the retina may be driven by the loss of the pigment epithelium-derived factor protein. The findings could pave the way for the development of treatment for age-related macular degeneration and other age-related vision loss disorders.
Exposure to multiple phthalates during pregnancy increases the risk for preterm birth, researchers report.
Blocking M2Rs muscarinic acetylcholine receptors in the lateral habenula with an experimental drug increased cocaine-seeking behaviors in rat models of impulsive behaviors.
The AREDS2 dietary supplement that substitutes antioxidants lutein and zeaxanthin for beta-carotene reduces the risk of age-related macular degeneration progression, a new study reveals.
Children diagnosed with ASD at 24 months had differences in visual processing areas of the brain which were apparent at six months of age, a new study reports.
Study reports a significant decline in smoking for those with major depression and substance use disorders, signifying smoking cessation treatments and campaigns are effective in targeting those in groups considered high risk for developing nicotine addiction.
While microsaccades appear to boost or diminish the strength of brain signals associated with attention, eye movements are not drivers for these brain signals.
An analysis of user posts from the Reddit r/selfharm forum found people who self-harm describe their activities as an "addiction", marked with characteristic cravings and an escalation in severity or tolerance.
3,6’-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer's disease against cognitive decline by reducing neuroinflammation.